Dianthus Therapeutics Inc.
DNTH | NASDAQ
$96.47
-$0.34 (-0.35%)
At close: Sep 21, 2026, 4:00 PM ET
$96.47
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $5.4B
Enterprise Value $4.51B
Beta 0.08
Average Volume 890.12K
Shares Outstanding (Diluted) 56.03M
Shares Change YoY 56.41%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US2528281080
Price Performance
Price Change 1M -12.4%
Price Change 3M 10.2%
Price Change 6M 21.2%
Price Change YTD 143.1%
Price Change 1Y 155.5%
Price Change 3Y 619.9%
Price Change 5Y -19.3%
1M CAGR (ann.) -11.4%
1Y CAGR (ann.) 148.2%
5Y CAGR (ann.) -0.8%
All-Time CAGR -10.1%
Valuation
PE Ratio -742.08
Forward PE N/A
PEG Ratio 122.51
Forward PEG -35.96
PS Ratio 2,834.03
Forward PS 2,661.20
PB Ratio 4.60
P/FCF Ratio -29.23
P/Adj. FCF Ratio -23.52
P/OCF Ratio -34.83
EV/Sales 2,368.94
EV/EBIT -150.81
EV/EBITDA -152.85
EV/FCF -24.44
Earnings Yield -0.1%
FCF Yield -3.4%
Adj. FCF Yield -4.3%
Financial Health
Net Cash $886.81M
Total Debt $1.29M
Cash & Short-Term Investments $886.81M
Total Assets $1.21B
Current Ratio 26.10
Quick Ratio 26.10
Debt / Equity Ratio 0.00
Debt / EBITDA -0.04
Debt / FCF -0.01
OCF / Debt -143.15
Interest Coverage 0.00
Altman Z-Score 78.78
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 96.0%
Operating Profit Margin -11441.4%
EBITDA Margin -1549.9%
Net Profit Margin -1570.8%
FCF Margin -9694.1%
Adj. FCF Margin -12050.9%
SBC / Revenue 1800.0%
SBC Impact (per share) -24.3%
Returns
Return on Assets -2.5%
Return on Equity -3.5%
Return on Invested Capital -18.5%
Return on Capital Employed -18.5%
Return on Tangible Assets -2.5%
Historical Growth (CAGR)
Revenue CAGR 3Y -20.5%
Revenue CAGR 5Y 16.6%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 100.0%
EPS CAGR 5Y 57.7%
EPS CAGR 10Y N/A
FCF CAGR 3Y -66.9%
FCF CAGR 5Y -40.9%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 11
EPS Growth Next 3Y -807.7%
Revenue Growth Next 3Y 405.1%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.94
EPS Growth Est (next Q) -2.7%
Revenue Est (next Q) $443.85K
Revenue Growth Est (next Q) 12.1%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $126.83
Price Target Upside 31.5%
Cash Flow
Operating Cash Flow $-184.23M
Free Cash Flow $-184.58M
Adj. Free Cash Flow $-229.45M
FCF Per Share -$2.78
OCF Per Share -$2.77
OCF/S Ratio -8160.5%
Income Statement
Revenue $1.9M
Gross Profit $1.83M
Operating Income $-217.84M
EBITDA $-29.51M
Net Income $-29.91M
EPS (Diluted) -$0.13
Revenue / Employee $20.7K
Profit / Employee $-325.1K
Employees 92
Add to Watchlist
Select watchlists to add or remove DNTH